RPAM
THC icon

Rhenman & Partners Asset Management’s Tenet Healthcare THC Stock Holding History

Rhenman & Partners Asset Management’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.9M Buy
85,200
+31,200
+58% +$5.74M 1.5% 23
2026
Q1 		$10.2M Sell
54,000
-22,504
-29% -$4.74M 1.26% 30
2025
Q4 		$15.2M Buy
76,504
+18,075
+31% +$3.65M 1.42% 31
2025
Q3 		$11.9M Sell
58,429
-78,000
-57% -$13.8M 1.31% 32
2025
Q2 		$24M Buy
136,429
+9,729
+8% +$1.46M 3.04% 6
2025
Q1 		$17M Sell
126,700
-71,000
-36% -$9.35M 1.96% 21
2024
Q4 		$25M Sell
197,700
-23,700
-11% -$3.52M 2.57% 10
2024
Q3 		$36.8M Sell
221,400
-7,600
-3% -$1.15M 2.99% 5
2024
Q2 		$30.5M Sell
229,000
-151,000
-40% -$18.2M 2.92% 7
2024
Q1 		$39.9M Buy
380,000
+28,370
+8% +$2.55M 3.79% 3
2023
Q4 		$26.6M Buy
351,630
+16,630
+5% +$1.05M 2.65% 10
2023
Q3 		$22.1M Buy
335,000
+45,000
+16% +$3.36M 2.38% 14
2023
Q2 		$23.6M Sell
290,000
-120,000
-29% -$8.54M 2.49% 12
2023
Q1 		$23.6M Sell
410,000
-60,750
-13% -$3.38M 2.59% 12
2022
Q4 		$23M Buy
470,750
+126,750
+37% +$5.86M 2.4% 11
2022
Q3 		$15.3M Buy
344,000
+83,000
+32% +$4.93M 1.6% 26
2022
Q2 		$13.7M Buy
261,000
+58,000
+29% +$4.04M 1.56% 21
2022
Q1 		$17.4M Sell
203,000
-7,000
-3% -$575K 1.72% 21
2021
Q4 		$17.2M Buy
210,000
+30,000
+17% +$2.19M 1.14% 35
2021
Q3 		$12M Buy
180,000
+95,000
+112% +$6.74M 0.84% 47
2021
Q2 		$5.69M Buy
+85,000
New +$5.27M 0.39% 76

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Rhenman & Partners Asset Management's THC Position: Q2 2026 in Review

Rhenman & Partners Asset Management increased its Tenet Healthcare (THC) stake by 58% in Q2 2026, buying an estimated $5.74M and bringing the position to 85,200 shares worth $15.9M. The position accounts for 1.5% of the portfolio, ranked #23.

Rhenman & Partners Asset Management first reported a position in THC in Q2 2021 and has held it in 21 quarters since. The position peaked at $39.9M in Q1 2024. 673 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Rhenman & Partners Asset Management held 85,200 shares of Tenet Healthcare worth $15.9M as of Q2 2026.
  • Rhenman & Partners Asset Management bought 31,200 Tenet Healthcare shares in Q2 2026, an estimated $5.74M.
  • Tenet Healthcare made up 1.5% of Rhenman & Partners Asset Management's portfolio in Q2 2026, its #23 holding.
  • Rhenman & Partners Asset Management first reported a position in Tenet Healthcare in Q2 2021 and has held it in 21 quarters since.
  • Rhenman & Partners Asset Management's Tenet Healthcare position peaked at $39.9M in Q1 2024.
  • 673 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Rhenman & Partners Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.